Business
Here’s why the Rhythm (ASX:RHY) share price hit an all-time high today
Shares in Rhythm Biosciences Ltd (ASX: RHY) are soaring higher during early afternoon trade. This comes after the company announced it has added two extra clinical trial sites for its ColoSTAT study.
Rhythm’s ColoSTAT is an experimental test-kit that is being trialled as a low-cost, easy-to-use blood test to detect colorectal cancer.
At the time of writing, the Rhythm share price is advancing 7.5% to $1.43 after reaching an-all time high of $1.47 around midday. In comparison, the All Ordinaries Index (ASX: XAO) is also moving higher, up 1.1% to 7,014 points.
Why is the Rhythm share price climbing?
Rhythm advised today that the Concord Repatriation General Hospital in Sydney’s inner west will participate in the ColoSTAT clinical…
-
General19 hours agoFrom jackaroo to ‘Golden Tonsils’ radio titan: the life and career of John Laws
-
General23 hours agoMajority of Australia’s first Ashes Test squad to feature in Sheffield Shield round four
-
General6 hours agoPrincess Anne remembers Porepunkah police officers in wreath-laying ceremony in Melbourne
-
General10 hours agoAFL gives teams finishing 10th chance to win premiership through wildcard round in finals